The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction

References

• George EM, Arany M, Cockrell K, et al. Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol 2011;301:R1495–500
   Web of Science ®Google Scholar
• Karthikeyan VJ, Lip GYH, Lane DA, Blann AD. Angiogenin and apoptosis in hypertension in pregnancy. Pregn Hypertens: Int J Women's Cardiovascular Health 2011;1:191–6
   Google Scholar
• Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 2010;37:239–53
   PubMed Web of Science ®Google Scholar
• Nasiell J, Nisell H, Blanck A, et al. Placental expression of endothelial constitutive nitric oxide synthase mRNA in pregnancy complicated by preeclampsia. Acta Obstet Gynecol Scand 1998;77:492–6
   PubMedGoogle Scholar
• Ortiz PA, Garvin JL. Trafficking and activation of eNOS in epithelial cells. Acta Physiol Scand 2003;179:107–14
   PubMedGoogle Scholar
• Kim YJ, Park HS, Lee HY, et al. Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. Placenta 2006;27:438–44
   PubMed Web of Science ®Google Scholar
• Zimmermann K, Opitz N, Dedio J, et al. NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2002;99:17167–72
   PubMedGoogle Scholar
• Schilling K, Opitz N, Wiesenthal A, et al. Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN. Mol Biol Cell 2006;17:3870–80
   PubMedGoogle Scholar
• Icking A, Matt S, Opitz N, et al. NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS. J Cell Sci 2005;118:5059–69
   PubMed Web of Science ®Google Scholar
• Schiessl B, Mylonas I, Hantschmann P, et al. Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem 2005;53:1441–9
   PubMed Web of Science ®Google Scholar
• Mookerjee RP, Wiesenthal A, Icking A, et al. Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis. Gastroenterology 2007;132:2533–41
   PubMedGoogle Scholar
• Zhang GG, Shi RZ, Jiang DJ, et al. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2. Life Sci 2008;82:699–707
   PubMed Web of Science ®Google Scholar
• Stepan H, Krämer T, Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauteirne growth restriction. J Clin Endocrinol Metab 2007;92:2831–4
   PubMed Web of Science ®Google Scholar
• Sessa WC. eNOS at a glance. J Cell Sci 2004;117:2427–9
   PubMed Web of Science ®Google Scholar
• Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 2002;64:749–74
   PubMed Web of Science ®Google Scholar
• Fulton D, Fontana J, Sowa G, et al. Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J Biol Chem 2002;277:4277–84
   PubMedGoogle Scholar
• Jiang J, Cyr D, Babbitt RW, et al. Chaperone-dependent regulation of endothelial nitric-oxide synthase intracellular trafficking by the co-chaperone/ubiquitin ligase CHIP. J Biol Chem 2003;278:49332–41
   PubMed Web of Science ®Google Scholar
• Myatt L, Eis AL, Brockman DE, et al. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod 1997;12:167–72
   PubMed Web of Science ®Google Scholar
• Beinder E, Mohaupt MG, Schlembach D, et al. Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia. Hypertens Pregn 1999;18:115–27
   PubMed Web of Science ®Google Scholar
• Xiang W, Chen H, Hu L, Xu X. Endothelial nitric oxide synthase traffic inducer in the umbilical vessels of the patients with pre-eclampsia. J Huazhong Univ Sci Technolog Med Sci 2009;29:243–5
   PubMedGoogle Scholar
• Xiang W, Chen H, Guo Y, Shen H. Expression of endothelial nitric oxide synthase traffic inducer in the placenta of pregnancy induced hypertension. J Huazhong Univ Sci Technolog Med Sci 2006;26:356–8
   PubMedGoogle Scholar
• Xiang W, Chen H, Xu X, et al. Expression of endothelial nitric oxide synthase traffic inducer in the placentas of women with pre-eclampsia. Int J Gynaecol Obstet 2005;89:103–7
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Impraim B, Simmel S, et al. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 2004;109:172–7
   PubMed Web of Science ®Google Scholar
• Savidou MD, Hingorani AD, Tsikas D, et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop preeclampsia. Lancet 2003;361:1511–17
   PubMedGoogle Scholar
• Pettersson A, Hedner T, Milsom I. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand 1998;77:808–13
   PubMed Web of Science ®Google Scholar
• Speer PD, Powers RW, Frank MP, et al. Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. Am J Obstet Gynecol 2008;198:112e1–e7
   Google Scholar
• Rizos D, Eleftheriades M, Batakis E, et al. Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby. J Matern Fetal Neonatal Med 2012;25:1311–15
   PubMed Web of Science ®Google Scholar
• Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1998;178:551–6
   PubMed Web of Science ®Google Scholar
• Mao D, Che J, Li K, et al. Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Arch Gynecol Obstet 2009;282:371–5
   PubMedGoogle Scholar